In this study, we investigated the autophagic status in preclinical breast cancer models exhibiting auto-acquired resistance to Tzb that were obtained by continuously growing Tzb-sensitive HER2-overexpressing SKBR3 breast cancer cells in the presence of clinically relevant concentrations of Tzb for more than 10 months. This evidence concerns the gene ERBB2 and breast cancer.